acorda shares soar on possible patent extension of ms drug
shares of acorda therapeutics inc jumped 27 percent before being halted amid optimism the company will be granted a patent extension on its multiple sclerosis drug ampyra.
http://feeds.reuters.com/~r/reuters/healthnews/~3/gprx9hqsy9s/us-acorda-idustre73d8gx20110414
30185
15 Apr 2011 00:02:17
reuters
health